Article info

Download PDFPDF
Aducanumab for Alzheimer’s disease – too many unanswered questions

Authors

  1. Correspondence to Mr David Phizackerley, Deputy Editor, DTB, BMJ Journals, London, UK; dphizackerley{at}bmj.com
View Full Text

Citation

Phizackerley D
Aducanumab for Alzheimer’s disease – too many unanswered questions

Publication history

  • First published July 20, 2021.
Online issue publication 
August 24, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.